- Home
- Products
- Customized ADCs
- TACSTD2
- Anti-TACSTD2-VC-MMAD ADC-2
Anti-TACSTD2-VC-MMAD ADC-2 (CAT#: ADC-W-568)
This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone C16) conjugated via a VC linker to MMAD. The MMAD is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- C16
- Name
- TACSTD2
- Alternative Names
- TACSTD2; tumor-associated calcium signal transducer 2; EGP1; GP50; M1S1; EGP-1; TROP2; GA7331; GA733-1; epithelial glycoprotein-1; cell surface glycoprotein TROP2; cell surface glycoprotein Trop-2; pancreatic carcinoma marker protein GA7331; pancreatic ca
- Target Entrez Gene ID
- 4070
- Target UniProt ID
- P09758
- Overview
- This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.
- Overview
- Anti-TACSTD2 Antibody, clone # C16
- Clone #
- C16
- Species Reactivity
- Human
- Name
- VC (valine-citrulline)
- Description
- Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Name
- MMAD (monomethyl auristatin D)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-SOST (Romosozumab)-SPDB-DM4 ADC (CAT#: ADC-W-1773)
- Anti-CD70-VC-AFP ADC-3 (CAT#: ADC-W-365)
- Anti-GPNMB (Glembatumumab)-SPDB-DM4 ADC (CAT#: ADC-W-2599)
- Anti-CD3E (Ertumaxomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2305)
- Anti-TNF (Golimumab)-SPDB-DM4 ADC (CAT#: ADC-W-1821)
- Anti-TAG-72 (Satumomab Pendetide)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2161)
- Anti-EGFR (Imgatuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1067)
- Anti-IL5 (Reslizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1398)
- Anti-EGFR-Mc-MMAF ADC-5 (CAT#: ADC-W-515)
- Anti-CD40LG (Toralizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-924)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-568. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-539 | Anti-TACSTD2-PEG6-Aur3377 ADC-2 | Amino-PEG6-based linker | Aur3377 |
| ADC-W-293 | Anti-TACSTD2-AcLys-VC-PABC-0101 ADC-1 | AcLys-VC- PABC (Acetyl-lysine-valine-citrulline-p-aminobenzyloxycarbonyl) | 2-methylalanyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide) |
| ADC-W-292 | Anti-TACSTD2-PEG6-MMAD ADC-1 | PEG6 ((Propylene Glycol)-6-propionyl) | MMAD (monomethyl auristatin D) |
| ADC-W-538 | Anti-TACSTD2-PEG6-MMAD ADC-2 | Amino-PEG6-based linker | MMAD (monomethyl auristatin D) |
| ADC-W-563 | Anti-TACSTD2-VC-PABC-Aur0101 ADC-2 | VC-PABC (valine-citrulline-p-aminobenzylcarbamate) | Aur0101 |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-048 | Protein G-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-536 | Anti-EDNRB (endothelin B)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-514 | Anti-ERBB2 (Trastuzumab)-VC-DUBA ADC | VC (valine-citrulline) | seco-DUBA (DUocarmycin hydroxyBenzamide Azaindole) |
| ADC-W-475 | Anti-CA9-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-AA-052 | Protein A-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-167 | Anti-TPBG-VC-MMAD ADC-11 | VC (valine-citrulline) | MMAD (monomethyl auristatin D) |
| ADC-W-570 | Anti-TACSTD2-Mc-VC-MMAD ADC-2 | Mc-VC (maleimidocaproyl-valine-alanine) | MMAD (monomethyl auristatin D) |
| ADC-W-632 | Anti-ERBB2 (trastuzumab)-Aminocaproyl-MMAD ADC | Aminocaproyl | MMAD (monomethyl auristatin D) |
| ADC-W-413 | Anti-ERBB2 (Trastuzumab)-hydroxyl amino PEG linker-MMAD (monomethyl auristatin D) ADC | hydroxyl amino PEG linker | MMAD (monomethyl auristatin D) |
| ADC-W-408 | Anti-ERBB2 (Trastuzumab)-MMAD ADC | Non-Cleavable hydroxyl amino PEG linker | MMAD (monomethyl auristatin D) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.